Methods of treating atherosclerosis and aneurysm
The technology described herein is directed to methods of treating cardiovascular and metabolic disorders.
1. A method comprising, administering a therapeutically effective amount of an IgE signaling inhibitor to a subject in need of a treatment for atherosclerosis, wherein the IgE inhibitor binds to IgE and inhibits the binding of IgE to a receptor molecule.
2. A method comprising, administering a therapeutically effective amount of an IgE signaling inhibitor to a subject in need of a treatment for abdominal aortic aneurysm, wherein the IgE inhibitor binds to IgE and inhibits the binding of IgE to a receptor molecule.
3. The method of claim 1 , wherein the IgE inhibitor is selected from the group consisting of; an IgE monoclonal antibody; omalizumab; and talizumab.
4. The method of claim 2 , wherein the IgE inhibitor is selected from the group consisting of; an anti-IgE monoclonal antibody; omalizumab; and talizumab.